Mimetogen Pharmaceuticals, Inc

Chantal Devin

Martin Hans Bohlin

Wei Tian

Sébastien Rocchi

The present disclosure relates to methods of preparing and crystallizing β-turn cyclic peptidomimetic salts of formula I: where R, R, R, R, R, R, R, R, R, X, Y and n are as defined in the specification. The present disclosure provides a more efficient route for preparing a crystalline form of a β-turn cyclic peptidomimetic compounds and salts thereof.

Solution phase synthesis of β-turn peptidomimetic cyclic salts

The present disclosure relates to methods of preparing and crystallizing &#x3b2;-turn cyclic peptidomimetic salts of formula I: where R, R, R, R, R, R, R, R, R, X, Y and n are as defined in the specification. The present disclosure provides a more efficient route for preparing a crystalline form of a &#x3b2;-turn cyclic peptidomimetic compounds and salts thereof.

Solution phase synthesis of beta-turn peptidomimetic cyclic salts

The present disclosure relates to methods of preparing and crystallizing &#x3b2;-turn cyclic peptidomimetic salts of formula I: where R, R, R, R, R, R, R, R, R, X, Y and n are as defined in the specification. The present disclosure provides a more efficient route for preparing a crystalline form of &#x3b2;-turn cyclic peptidomimetic compounds and salts thereof.

Growing community of inventors

Lingolsheim, France

Chantal Devin